INVIVO THERAPEUTICS HOLDINGS CORP. 4
4 · INVIVO THERAPEUTICS HOLDINGS CORP. · Filed Dec 11, 2015
Insider Transaction Report
Form 4
Ulich Thomas R
Chief Scientific Officer
Transactions
- Award
Stock Option (Right To Buy)
2015-12-10+115,050→ 115,050 totalExercise: $7.37Exp: 2025-12-10→ Common Stock (115,050 underlying)
Footnotes (1)
- [F1]The option is exercisable as to 25% of the shares on the first anniversary of the date of grant, and the remaining shares vest thereafter on a monthly basis in 36 equal monthly installments.